“…In recent years, there has been a growing interest in the development of optimized interfaces capable of supporting the detection of clinically relevant analytes, especially those translatable to rapid low cost analyses. − Derived immunosensors ,− (which translate a biological biomarker recognition into a measurable signal) have been based on a variety of electrochemical techniques, such as voltammetry, amperometry, , and electrochemical impedance spectroscopy (EIS). − EIS is a natively spectroscopic and highly sensitive method within which interfacial charge transfer resistance R ct is most commonly assessed as a reporter of analyte recognition. , Recently we introduced electrochemical impedance-derived capacitive spectroscopy ,− as a label-free, reagentless method of mapping the change in interfacial redox capacitance ( C r ) as a transducer, omitting the need for a solution phase redox-probe. ,− The partition of mobile electrons between an electrode and a surface tethered chargeable (redox or quantum) species generates a spectroscopically resolvable capacitance. We have shown that this interfacial signal is fundamentally quantum mechanical in nature − and that the charging signature is highly sensitive to changes in local environment. ,, When incorporated into a redox addressable molecular film capable of selectively binding an analyte, C r can (where the binding site is in close proximity) become a sensitive function of target concentration. To date, such interfaces have been created by covalent immobilization of bioreceptors within a mixed self-assembled monolayer (SAM), one film component being redox active, the second serving as a receptor anchor. ,, …”